Specialty Medicines Market Access Patient Safety
Knowledge Center

Frequently Asked Questions

Clear answers about EndoCare+, our therapeutic focus, quality framework, market access capabilities, distribution operations, and pharmacovigilance.

About EndoCare+

What is EndoCare+?
EndoCare+ is a specialized biopharmaceutical distributor in Yemen, dedicated to importing, distributing, and providing market access for advanced hormonal therapies, biopharmaceuticals, and specialty medicines.
What therapeutic areas does EndoCare+ focus on?
We focus exclusively on endocrine therapies, reproductive health, metabolic therapies, and specialized biopharmaceuticals, ensuring targeted expertise in these critical medical areas.
Where does EndoCare+ operate?
EndoCare+ operates in Yemen, coordinating distribution through an established commercial and logistics network that currently covers 16 governorates, with delivery arrangements depending on product requirements and destination.
Who does EndoCare+ serve?
We serve healthcare professionals, hospitals, specialized clinics, retail pharmacies, and international pharmaceutical manufacturers seeking reliable market access and distribution within Yemen.

Products & Market Access

What types of products does EndoCare+ handle?
We handle biopharmaceuticals, endocrine therapies, hormonal treatments, reproductive health products, metabolic therapies, and other specialty medicines that require strict temperature control and specialized handling.
Does EndoCare+ support the introduction of specialty and biopharmaceutical products into Yemen?
Yes. We support the introduction of specialty products through regulatory coordination, commercial representation, and specialized distribution capabilities tailored for sensitive biopharmaceuticals.
Can international pharmaceutical companies partner with EndoCare+?
Yes. We work with international companies looking for Yemen market access, distribution, commercial representation, regulatory coordination, and specialty product commercialization. Partnerships are evaluated based on therapeutic fit and regulatory status.
How can manufacturers discuss distribution or market access opportunities?
Manufacturers can contact our business development team to discuss product portfolio, therapeutic fit, and market opportunities through the Contact Us page.

Quality & Distribution

How does EndoCare+ manage temperature-sensitive products?
We manage temperature-sensitive products through documented cold-chain procedures, maintaining temperature-controlled environments (such as 2°C - 8°C) during both storage and transit to preserve molecular stability.
How are products handled during storage and distribution?
Storage and distribution are managed according to documented procedures and applicable regulatory requirements, ensuring product integrity is maintained from receipt to delivery.
How does EndoCare+ support product traceability?
We maintain documented product traceability procedures, allowing us to track product batches throughout the distribution lifecycle, which is critical for quality control and recall readiness.
Can customers request product quality documentation?
Quality and product documentation may be provided to qualified customers and institutional partners according to product, manufacturer, regulatory, and commercial requirements.
How does EndoCare+ handle product quality or recall-related concerns?
Product quality and recall-related concerns are escalated through applicable quality and regulatory procedures, with coordination between relevant internal teams, manufacturers, and authorities where required.

Pharmacovigilance & Patient Safety

How can I report a suspected adverse reaction?
You can submit a report through our secure Pharmacovigilance reporting form. The form allows you to provide details regarding the event, product, and patient safely and confidentially.
Who can submit a safety report?
Healthcare professionals, patients, caregivers, business partners, and other individuals with relevant safety information are encouraged to report suspected adverse events.
What information should I provide when reporting an adverse event?
Please provide the product name, patient information where appropriate (without full identifying details), description of the event, date of onset, batch number if available, and reporter contact information.
What happens after I submit a safety report?
Reports are managed through a 5-step process: Receive, Record, Assess, Follow-up, and Escalate/Report, ensuring cases are handled in accordance with applicable regulatory requirements.
How can I report a product quality complaint?
Product quality complaints (such as packaging defects or physical damage) should be directed through our Quality & Safety page, separate from adverse event reporting.

Business & Partnership

Does EndoCare+ work with international manufacturers?
Yes, we partner with international pharmaceutical and biopharmaceutical manufacturers looking for a reliable specialized distributor to facilitate market access and commercialization in Yemen.
What information is required to evaluate a potential partnership?
We typically review the product portfolio, therapeutic fit, regulatory status, market opportunity, and commercial model to ensure alignment with our specialized therapeutic focus.
How can a pharmaceutical company contact the business development team?
You can reach our business development team by visiting the Contact Us page or by submitting an inquiry through the About Us section.
How can hospitals or institutional customers request a quotation?
Hospitals, healthcare institutions, and qualified business customers can contact our commercial team to discuss product availability, quantities, delivery requirements, and quotation requests.

Still have a question?

Our team is available to assist with product, quality, pharmacovigilance, and partnership-related inquiries.